Market Cap	2.37M 2.06M 1.9M 1.79M 3.35M 223M 3.37M 22.63M 8.79M 110M 8.89M 8.7M 381M	P/E 2022	-0.43x	P/E 2023	-1.56x
Enterprise Value	10.6M 9.24M 8.52M 8.01M 14.98M 999M 15.09M 101M 39.34M 492M 39.79M 38.94M 1.71B	EV / Sales 2022	3.94x	EV / Sales 2023	3.15x
Free-Float	98.82%	Yield 2022 *	-	Yield 2023	-

* Estimated data More valuation ratios

Latest news : CURE Pharmaceutical Holding Corp.

25-03-04	Avenir Wellness Solutions, Inc. Announces CEO Changes	CI
24-11-19	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-10-02	CURE Pharmaceutical Appoints Raymond Watt to Board of Directors	CI
24-08-14	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-06-27	Avenir Wellness Solutions, Inc. announced that it expects to receive $0.1219 million in funding	CI
24-05-30	Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-05-17	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-05-16	Avenir Wellness Solutions, Inc. Auditor Raises 'Going Concern' Doubt	CI
24-01-12	Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement	CI
24-01-03	Avenir Wellness Solutions, Inc. announced that it expects to receive $0.25 million in funding	CI
23-11-14	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-15	Avenir Wellness Solutions, Inc. Provides Sales Guidance for the Second Half of 2023	CI
23-08-14	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Press Releases: CURE Pharmaceutical Holding Corp.

24-10-09	Avenir Wellness : Amendment to Quarterly Report Form 10 Q/A	PU
24-10-01	CURE Pharmaceutical Appoints Raymond Watt to Board of Directors	AQ
23-08-16	Avenir Wellness Solutions Reports Second Quarter 2023 Results	AQ
23-08-01	Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year over Year Revenue Increases and Continued High Gross Margins	AQ
23-05-22	AVENIR WELLNESS SOLUTIONS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ

More press releases

Managers and Directors: CURE Pharmaceutical Holding Corp.

Manager	Title	Age	Since
Joel Bennett CEO	Chief Executive Officer	64	2025-02-28
Bhaumik Patel CTO	Chief Tech/Sci/R&D Officer	-	2019-05-19
Marian McNear SAM	Sales & Marketing	-	-

Director	Title	Age	Since
Robert Davidson CHM	Chairman	59	2022-08-15
Gene Salkind BRD	Director/Board Member	72	2017-12-31
Nancy Duitch BRD	Director/Board Member	71	2020-10-22

More insiders

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Companyâ€™s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.

Employees

Sector

Software

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CURE PHARMACEUTICAL HOLDING CORP.	+3.25%	-2.07%	-	-	18.04K
MICROSOFT CORPORATION	+0.13%	-2.80%	-21.00%	+10.83%	2,815B
PALANTIR TECHNOLOGIES INC.	-1.65%	-1.99%	-8.21%	+688.16%	313B
CAMBRICON TECHNOLOGIES CORPORATION LIMITED	+14.20%	+23.61%	+284.67%	+907.90%	123B
CADENCE DESIGN SYSTEMS, INC.	-0.57%	+0.95%	+30.50%	+64.26%	107B
SYNOPSYS, INC.	-1.35%	-0.17%	-3.82%	+3.25%	88.41B
DATADOG, INC.	-1.60%	-4.80%	+71.49%	+132.90%	80.67B
SEA LIMITED	+0.48%	+6.52%	-41.37%	+47.04%	55.64B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+4.93%	+12.83%	+0.33%	+72.59%	42.34B
ROBLOX CORPORATION	+7.31%	+18.49%	-49.80%	+23.28%	34.38B
Average	+2.77%	+6.11%	+29.20%	+216.69%	406.61B
Weighted average by Cap.	+0.57%	-1.17%	-6.02%	+104.33%

	2022	2023
Net sales	4.9M 4.27M 3.93M 3.7M 6.92M 461M 6.97M 46.79M 18.17M 227M 18.38M 17.98M 788M	4.35M 3.79M 3.49M 3.28M 6.14M 410M 6.19M 41.54M 16.13M 202M 16.32M 15.97M 700M
Net income	-25.51M -22.23M -20.49M -19.27M -36.05M -2.4B -36.31M -244M -94.67M -1.18B -95.75M -93.7M -4.11B	-3.44M -3M -2.77M -2.6M -4.87M -325M -4.9M -32.91M -12.78M -160M -12.93M -12.65M -554M
Net Debt	7.12M 6.2M 5.72M 5.38M 10.06M 671M 10.13M 68.02M 26.42M 331M 26.72M 26.15M 1.15B	8.23M 7.17M 6.61M 6.22M 11.64M 776M 11.72M 78.68M 30.56M 382M 30.91M 30.24M 1.33B

CURE Pharmaceutical Holding Corp. Stock Other OTC

Stocks

CURR

US23127P1049

Software

Valuation: CURE Pharmaceutical Holding Corp.

Latest news : CURE Pharmaceutical Holding Corp.

Press Releases: CURE Pharmaceutical Holding Corp.

Quotes and Performance

Managers and Directors: CURE Pharmaceutical Holding Corp.

Other Software

Financials

Company Profile